Scroll Up
Scroll Down
Play Play Play Play
Unregistered User
Click here if this is not your Personal Edition
 
Contact Us | Free E-Mail Updates | Journals | Register a colleague
 
 
Dermatology Other
 
   
 
SEARCH   
Doctor's Guide Free CME
Medline
Congress Resource Centre
 

 EXPLORE :
   Most Read News
 All News  All News
 All Webcasts / CME  All Webcasts / CME
 All Cases  All Cases
 Congress Resource Centre  Congress Resource Centre
 All Medical Resources  All Medical Resources
 Medical  My Personal Edition



Warning | Privacy

 

 
 Recent news - Dermatology Other
    Converting to Sirolimus From Calcineurin Inhibitors Reduces Risk of Skin Cancer in Kidney Transplant Patients: Presented at Renal Week 2009 - (DGDispatch)
    Spinosad Better Than Permethrin for Pediculosis Capitis in Children: Presented at AAP - (DGDispatch)
    Topical Onychomycosis Treatment More Effective Than Oral Treatment : Presented at EADV - (DGDispatch)
    Mycophenolate Mofetil Benefits Patients With Pemphigus Vulgaris: Presented at EADV - (DGDispatch)
    Health Canada Approves Telavancin for Complicated Skin, Skin Structure Infections - (DGNews)

    News archive

     Recent webcasts/CME - Dermatology Other
      The Prevention and Treatment of Pressure Ulcers
      Contemporary Options for the Management of Scars
      Pediatric and Adolescent Sports-Related Injuries and Ailments
      The Wound Healing Process
      Current Concepts in Healing Chronic Diabetic Foot Ulcerations

      Webcasts/CME archive

       Recent cases - Dermatology Other
        Yellow Nail Syndrome
        Acquired Perforating Dermatosis: Association with Diabetes and Renal Failure
        Complete Remission of Severe Idiopathic Cold Urticaria on Interleukin-1 Receptor Antagonist (Anakinra)
        Ulcerative Leg Nodules in a Transplant Recipient
        Pearly Penile Papules

        Cases archive
          




        my personal edition > dermatology other > news
        divider

          E-Mail this DGReview to a colleague

        DGReview


        Polidocanol And Sodium Tetradecyl Sulfate Effectively Treat Varicose And Telagiectatic Veins

        A DGReview of :"Treatment of Varicose and Telangiectatic Leg Veins: Double-Blind Prospective Comparative Trial Between Aethoxyskerol and Sotradecol"
        Dermatologic Surgery

        03/26/2002
        By Veronica Rose


        Polidocanol or sodium tetradecyl sulfate appear both safe and effective sclerosing solution for varicose and telangiectatic leg veins.

        Researchers from the Department of Dermatology at the University of California, in San Diego, California, San Diego, United States designed a study comparing the efficacy and safety of the two sclerosing solutions. One hundred and twenty nine patients with varicose or telangiectatic veins were enrolled for treatment with either polidocanol (POL) or sodium tetradecyl solution.

        The leg veins of each patient, which lacked incompetence from the saphenofemoral junction (SFJ), were divided into three categories according to size (<1 mm, 1-3 mm, and 3-6 mm). Treatment was then undertaken randomly with either sodium tetradecyl sulfate at these percentages 0.25, 0.5 or 1.5, or polidocanol 0.5, I.0 or 3 respective of size.

        Prior to treatment, an independent, three panel, blindly randomized photographic examination was obtained. This was repeated at four and 16 weeks. Researchers also included the patient satisfaction index and overall clinical improvement assessment.

        Patients all showed a 70 percent improvement and expressed a 70-72 percent satisfaction in all vein categories treated, regardless of solution. No significant differences were identified in adverse effects between each group, with the exception of decreased ulcerations and swelling in the group treated with polidocanol.
        Dertmatologic Surgery 2002 Vol 28 No 1 pp 52. "Treatment of Varicose and Telangiectatic Leg Veins: Double-Blind Prospective Comparative Trial Between Aethoxyskerol and Sotradecol"

        E-Mail this DGReview to a colleague   To print, use this version






        All contents Copyright (c) 1995-2009 Doctor's Guide Publishing Limited. All rights reserved.



        The NTK initiative. Physicians helping physicians identify Need-To-Know science
           Feedback
        Please rate this article: Strongly DISAGREE...Strongly AGREE NTK logo
        Question 1 - Physicians need to become aware of this information as soon as possible. Question 2 - This information is likely to have an impact on the way physicians practice medicine.
        1
        2
        3
        4
        5
        6
        7
        Send